• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.

作者信息

Valero Marta, Sanchez-Piedra Carlos, Freire Mercedes, Colazo Maria, Busquets Noemi, Merino-Ibarra Erardo, Rodriguez-Lozano Carlos, Manrique Sara, Campos Cristina, Sanchez-Alonso Fernando, Castrejon Isabel

机构信息

Servicio de Reumatologia, Hospital Universitario Ramon Y CajalInstituto Ramon Y Cajal de Investigacion Sanitaria (IRYCIS), Carretera de Colmenar Viejo Km: 9,100, 28034, Madrid, Spain.

Health Technology Assessment Agency of Carlos III Institute of Health (ISCIII), Madrid, Spain.

出版信息

Arthritis Res Ther. 2023 Oct 25;25(1):210. doi: 10.1186/s13075-023-03194-5.

DOI:10.1186/s13075-023-03194-5
PMID:37880797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10598974/
Abstract
摘要

相似文献

1
Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.更正：缓解期炎性关节炎患者生物制剂停药的相关因素：来自BIOBADASER注册研究的数据
Arthritis Res Ther. 2023 Oct 25;25(1):210. doi: 10.1186/s13075-023-03194-5.
2
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.与缓解期炎症性关节炎患者停用生物制剂相关的因素：来自 BIOBADASER 登记处的数据。
Arthritis Res Ther. 2023 May 22;25(1):86. doi: 10.1186/s13075-023-03045-3.
3
Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry.与类风湿患者从 BIOBADASER III 登记处停止 ts/bDMARDs 治疗相关的临床因素。
Sci Rep. 2021 May 27;11(1):11091. doi: 10.1038/s41598-021-90442-w.
4
Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry.
Musculoskeletal Care. 2022 Jun;20(2):403-407. doi: 10.1002/msc.1595. Epub 2021 Oct 19.
5
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register.年龄对生物治疗起始时风湿患者不良事件发生的影响：来自 BIOBADASER III 登记处的数据。
Arthritis Res Ther. 2020 Jun 15;22(1):143. doi: 10.1186/s13075-020-02231-x.
6
Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER.肿瘤坏死因子拮抗剂在脊柱关节炎中的留存率高于类风湿关节炎。来自西班牙BIOBADASER注册研究的数据。
Arthritis Res Ther. 2006;8(3):R72. doi: 10.1186/ar1941. Epub 2006 Apr 18.
7
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.TNF 拮抗剂治疗的风湿患者中的脱髓鞘疾病：来自 BIOBADASER 药物警戒数据库和系统评价的数据。
Semin Arthritis Rheum. 2011 Dec;41(3):524-33. doi: 10.1016/j.semarthrit.2011.05.003.
8
Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.TNF 拮抗剂治疗的风湿患者中的脱髓鞘疾病：来自 BIOBADASER 药物警戒数据库和系统评价的数据。
Semin Arthritis Rheum. 2011 Feb;40(4):330-7. doi: 10.1016/j.semarthrit.2010.06.004. Epub 2010 Sep 22.
9
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period.慢性关节炎患者更换肿瘤坏死因子拮抗剂：一项对488例患者进行的为期四年的观察性研究。
Arthritis Res Ther. 2006;8(1):R29. doi: 10.1186/ar1881. Epub 2006 Jan 6.
10
Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0.10 年来类风湿关节炎中肿瘤坏死因子拮抗剂停药模式的变化：来自西班牙登记处 BIOBADASER 2.0 的数据。
Ann Rheum Dis. 2012 Mar;71(3):382-5. doi: 10.1136/annrheumdis-2011-200302. Epub 2011 Oct 13.

本文引用的文献

1
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.与缓解期炎症性关节炎患者停用生物制剂相关的因素：来自 BIOBADASER 登记处的数据。
Arthritis Res Ther. 2023 May 22;25(1):86. doi: 10.1186/s13075-023-03045-3.